Conformational changes in DNA upon ligand binding monitored by circular dichroism

International Journal of Molecular Sciences

Volumn 13, Issue 3, 2012, Pages 3394-3413

  Chang, Yu Ming ^a   Chen, Cammy K M ^a   Hou, Ming Hon ^b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Circular dichroism; Conformational changes; DNA structure; DNA binding drugs; Thermodynamic parameters

Indexed keywords

ANTINEOPLASTIC AGENT; BLENOMYCIN; CHROMOMYCIN A3; CISPLATIN; DACTINOMYCIN; DIMINAZENE ACETURATE; DISTAMYCIN A; DNA; DNA A; DNA B; DNA QUADRUPLEX; DNA TRIPLEX; DNA Z; DOXORUBICIN; LAMIVUDINE; MITHRAMYCIN; MITOMYCIN C; NEOMYCIN; NOGALAMYCIN; PHENANTHROLINE; POLYAMINE; RACHELMYCIN; RUFOCROMOMYCIN; SABARUBICIN; SN 18071; SN 6999; SN 7167; TARTRAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; ANTIVIRUS AGENT; LIGAND;

ANTINEOPLASTIC ACTIVITY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DNA CONFORMATION; DNA DRUG COMPLEX; DNA POLYMORPHISM; DRUG DNA BINDING; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HYPERCALCEMIA; LIGAND BINDING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; REVIEW; SENSITIVITY ANALYSIS; TESTIS CANCER; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; METABOLISM; NUCLEOTIDE SEQUENCE; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BASE SEQUENCE; CIRCULAR DICHROISM; DNA; HUMANS; LIGANDS; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION;

EID: 84858995190     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13033394     Document Type: Review

References (90)

1. Woody, R.W. Circular dichroism. Meth. Enzymology 1995, 246, 34-71.
2. Lewis, D.G.; Johnson, W.C., Jr. Circular dichroism of DNA in the vacuum ultraviolet. J. Mol. Biol. 1974, 86, 91-96.
3. Holm, A.I.; Nielsen, L.M.; Hoffmann, S.V.; Nielsen, S.B. Vacuum-ultraviolet circular dichroism spectroscopy of DNA: A valuable tool to elucidate topology and electronic coupling in DNA. Phys. Chem. Chem. Phys. 2010, 12, 9581-996.
4. Matsuo, K.; Yonehara, R.; Gekko, K. Secondary-structure analysis of proteins by vacuum-ultraviolet circular dichroism spectroscopy. J. Biochem. 2004, 135, 405-411.
5. Sreerama, N.; Venyaminov, S.Y.; Woody, R.W. Estimation of protein secondary structure from circular dichroism spectra: Inclusion of denatured proteins with native proteins in the analysis. Anal. Biochem. 2000, 287, 243-251.
6. Porumb, H.; Monnot, M.; Fermandjian, S. Circular dichroism signatures of features simultaneously present in structured guanine-rich oligonucleotides: A combined spectroscopic and electrophoretic approach. Electrophoresis 2002, 23, 1013-1020.
7. Zhou, J.; Yuan, G. Specific recognition of human telomeric G-quadruplex DNA with small molecules and the conformational analysis by ESI mass spectrometry and circular dichroism spectropolarimetry. Chemistry 2007, 13, 5018-5023.
8. Andrushchenko, V.; Bour, P. Applications of the Cartesian coordinate tensor transfer technique in the simulations of vibrational circular dichroism spectra of oligonucleotides. Chirality 2010, 22, E96-E114.
9. Daura, X.; Bakowies, D.; Seebach, D.; Fleischhauer, J.; van Gunsteren, W.F.; Kruger, P. Circular dichroism spectra of beta-peptides: Sensitivity to molecular structure and effects of motional averaging. Eur. Biophys. J. 2003, 32, 661-670.
10. Kypr, J.; Kejnovska, I.; Renciuk, D.; Vorlickova, M. Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res. 2009, 37, 1713-1725.
11. Kankia, B.I.; Buckin, V.; Bloomfield, V.A. Hexamminecobalt(III)-induced condensation of calf thymus DNA: Circular dichroism and hydration measurements. Nucleic Acids Res. 2001, 29, 2795-2801.
12. Maestre, M.F. Circular dichroism of DNA films: Reversibility studies. J. Mol. Biol. 1970, 52, 543-556.
13. Boer, D.R.; Canals, A.; Coll, M. DNA-binding drugs caught in action: The latest 3D pictures of drug-DNA complexes. Dalton Trans. 2009, No. 3, 399-414.
14. Palchaudhuri, R.; Hergenrother, P.J. DNA as a target for anticancer compounds: Methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotechnol. 2007, 18, 497-503.
15. Watson, J.D.; Crick, F.H. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953, 171, 737-738.
16. Nelson, H.C.; Finch, J.T.; Luisi, B.F.; Klug, A. The structure of an oligo(dA)·oligo(dT) tract and its biological implications. Nature 1987, 330, 221-226.
17. Alexeev, D.G.; Lipanov, A.A.; Skuratovskii, I. Poly(dA)·poly(dT) is a B-type double helix with a distinctively narrow minor groove. Nature 1987, 325, 821-823.
18. Trantirek, L.; Stefl, R.; Vorlickova, M.; Koca, J.; Sklenar, V.; Kypr, J. An A-type double helix of DNA having B-type puckering of the deoxyribose rings. J. Mol. Biol. 2000, 297, 907-922.
19. Ivanov, V.I.; Minchenkova, L.E.; Minyat, E.E.; Frank-Kamenetskii, M.D.; Schyolkina, A.K. The B to A transition of DNA in solution. J. Mol. Biol. 1974, 87, 817-833.
20. Stefl, R.; Trantirek, L.; Vorlickova, M.; Koca, J.; Sklenar, V.; Kypr, J. A-like guanine-guanine stacking in the aqueous DNA duplex of d(GGGGCCCC). J. Mol. Biol. 2001, 307, 513-524.
21. Jaworski, A.; Hsieh, W.T.; Blaho, J.A.; Larson, J.E.; Wells, R.D. Left-handed DNA in vivo. Science 1987, 238, 773-777.
22. Lezius, A.G.; Gottschalk, E.M. Areversible cooperative conformational change of a synthetic DNA under the influence of high salt concentrations. Hoppe-Seylers Z. Physiol. Chem. 1970, 351, 413-416.
23. Ivanov, V.I.; Minyat, E.E. The transitions between left- and right-handed forms of poly(dG-dC). Nucleic Acids Res. 1981, 9, 4783-4798.
24. Balagurumoorthy, P.; Brahmachari, S.K.; Mohanty, D.; Bansal, M.; Sasisekharan, V. Hairpin and parallel quartet structures for telomeric sequences. Nucleic Acids Res. 1992, 20, 4061-4067.
25. Dapic, V.; Abdomerovic, V.; Marrington, R.; Peberdy, J.; Rodger, A.; Trent, J.O.; Bates, P.J. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. Nucleic Acids Res. 2003, 31, 2097-2107.
26. Paramasivan, S.; Rujan, I.; Bolton, P.H. Circular dichroism of quadruplex DNAs: Applications to structure, cation effects and ligand binding. Methods 2007, 43, 324-331.
27. Foley, J.M. The size-distance relation and intrinsic geometry of visual space: Implications for processing. Vision Res. 1972, 12, 323-332.
28. Du Priest, R.W., Jr.; Fletcher, W.S. Chemotherapy of testicular germinal tumors. Oncology 1973, 28, 147-163.
29. Lu, W.J.; Wang, H.M.; Yuann, J.M.; Huang, C.Y.; Hou, M.H. The impact of spermine competition on the efficacy of DNA-binding Fe(II), Co(II), and Cu(II) complexes of dimeric chromomycin A(3). J. Inorg. Biochem. 2009, 103, 1626-1633.
30. Altaner, C.; Ban, J.; Zajac, V.; Rossler, H.; Rosenthal, S.; Kettmann, R.; Burny, A. Isolation and characterization of cell clones producing various amounts of bovine leukosis virus. Folia Biol. (Praha) 1985, 31, 107-114.
31. Chakrabarti, S.; Aich, P.; Sarker, D.; Bhattacharyya, D.; Dasgupta, D. Role of Mg2+ in the interaction of anticancer antibiotic, chromomycin A3 with DNA: Does neutral antibiotic bind DNA in absence of the metal ion? J. Biomol. Struct. Dyn. 2000, 18, 209-218.
32. Aich, P.; Sen, R.; Dasgupta, D. Role of magnesium ion in the interaction between chromomycin A3 and DNA: Binding of chromomycin A3-Mg2+ complexes with DNA. Biochemistry 1992, 31, 2988-2997.
33. Devi, P.G.; Pal, S.; Banerjee, R.; Dasgupta, D. Association of antitumor antibiotics, mithramycin and chromomycin, with Zn(II). J. Inorg. Biochem. 2007, 101, 127-137.
34. Hou, M.H.; Lu, W.J.; Lin, H.Y.; Yuann, J.M. Studies of sequence-specific DNA binding, DNA cleavage, and topoisomerase I inhibition by the dimeric chromomycin A3 complexed with Fe(II). Biochemistry 2008, 47, 5493-5502.
35. Slavik, M.; Carter, S.K. Chromomycin A3, mithramycin, and olivomycin: Antitumor antibiotics of related structure. Adv. Pharmacol. Chemother. 1975, 12, 1-30.
36. Goldberg, I.H.; Friedman, P.A. Antibiotics and nucleic acids. Annu. Rev. Biochem. 1971, 40, 775-810.
37. Yang, X.L.; Wang, A.H. Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol. Ther. 1999, 83, 181-215.
38. Kennedy, B.J. Mithramycin therapy in testicular cancer. J. Urol. 1972, 107, 429-432.
39. Elias, E.G.; Evans, J.T. Mithramycin in the treatment of Paget's disease of bone. J. Bone Joint Surg. Am. 1972, 54, 1730-1736.
40. Fibach, E.; Bianchi, N.; Borgatti, M.; Prus, E.; Gambari, R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 2003, 102, 1276-1281.
41. Hou, M.H.; Wang, A.H. Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity. Nucleic Acids Res. 2005, 33, 1352-1361.
42. Sobell, H.M.; Jain, S.C. Stereochemistry of actinomycin binding to DNA. II. Detailed molecular model of actinomycin-DNA complex and its implications. J. Mol. Biol. 1972, 68, 21-34.
43. Kamitori, S.; Takusagawa, F. Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. J. Mol. Biol. 1992, 225, 445-456.
44. Hurwitz, J.; Furth, J.J.; Malamy, M.; Alexander, M. The role of deoxyribonucleic acid in ribonucleic acid synthesis. III. The inhibition of the enzymatic synthesis of ribonucleic acid and deoxyribonucleic acid by actinomycin D and proflavin. Proc. Natl. Acad. Sci. USA 1962, 48, 1222-1230.
45. Aivasashvilli, V.A.; Beabealashvilli, R.S. Sequence-specific inhibition of RNA elongation by actinomycin D. FEBS Lett. 1983, 160, 124-128.
46. Chen, F.M. Kinetic and equilibrium binding studies of actinomycin D with some d(TGCA)-containing dodecamers. Biochemistry 1988, 27, 1843-1848.
47. Margolis, R.L.; O'Hearn, E.; Rosenblatt, A.; Willour, V.; Holmes, S.E.; Franz, M.L.; Callahan, C.; Hwang, H.S.; Troncoso, J.C.; Ross, C.A. A Disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann. Neurol. 2001, 50, 373-380.
48. Seznec, H.; Agbulut, O.; Sergeant, N.; Savouret, C.; Ghestem, A.; Tabti, N.; Willer, J.C.; Ourth, L.; Duros, C.; Brisson, E.; et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 2001, 10, 2717-2726.
49. Paulson, H.L.; Fischbeck, K.H. Trinucleotide repeats in neurogenetic disorders. Annu. Rev. Neurosci. 1996, 19, 79-107.
50. Hou, M.H.; Robinson, H.; Gao, Y.G.; Wang, A.H. Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases. Nucleic Acids Res. 2002, 30, 4910-4917.
51. Hou, M.H.; Lin, S.B.; Yuann, J.M.; Lin, W.C.; Wang, A.H.; Kan Ls, L. Effects of polyamines on the thermal stability and formation kinetics of DNA duplexes with abnormal structure. Nucleic Acids Res. 2001, 29, 5121-5128.
52. N'Soukpoe-Kossi, C.N.; Ouameur, A.A.; Thomas, T.; Shirahata, A.; Thomas, T.J.; Tajmir-Riahi, H.A. DNA interaction with antitumor polyamine analogues: A comparison with biogenic polyamines. Biomacromolecules 2008, 9, 2712-2718.
53. Ouameur, A.A.; Bourassa, P.; Tajmir-Riahi, H.A. Probing tRNA interaction with biogenic polyamines. RNA 2010, 16, 1968-1979.
54. N'Soukpoe-Kossi, C.N.; Ahmed Ouameur, A.; Thomas, T.; Thomas, T.J.; Tajmir-Riahi, H.A. Interaction of tRNA with antitumor polyamine analogues. Biochem. Cell Biol. 2009, 87, 621-630.
55. Marty, R.; N'Soukpoe-Kossi, C.N.; Charbonneau, D.M.; Kreplak, L.; Tajmir-Riahi, H.A. Structural characterization of cationic lipid-tRNA complexes. Nucleic Acids Res. 2009, 37, 5197-5207.
56. Igarashi, K.; Kashiwagi, K. Polyamines: Mysterious modulators of cellular functions. Biochem. Biophys. Res. Commun. 2000, 271, 559-564.
57. Patel, A.R.; Wang, J.Y. Polyamine depletion is associated with an increase in JunD/AP-1 activity in small intestinal crypt cells. Am. J. Physiol. 1999, 276, G441-G450.
58. Panagiotidis, C.A.; Artandi, S.; Calame, K.; Silverstein, S.J. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res. 1995, 23, 1800-1809.
59. Frugier, M.; Florentz, C.; Hosseini, M.W.; Lehn, J.M.; Giege, R. Synthetic polyamines stimulate in vitro transcription by T7 RNA polymerase. Nucleic Acids Res. 1994, 22, 2784-2790.
60. Wang, Y.; Devereux, W.; Stewart, T.M.; Casero, R.A., Jr. Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine N1-acetyltransferase (SSAT) gene. Biochem. J. 2001, 355, 45-49.
61. Westerhoff, H.V.; O'Dea, M.H.; Maxwell, A.; Gellert, M. DNA supercoiling by DNA gyrase. A static head analysis. Cell Biophys. 1988, 12, 157-181.
62. Pommier, Y.; Kerrigan, D.; Kohn, K. Topological complexes between DNA and topoisomerase II and effects of polyamines. Biochemistry 1989, 28, 995-1002.
63. Gao, Y.G.; Robinson, H.; Wang, A.H. High-resolution A-DNA crystal structures of d(AGGGGCCCCT). An A-DNA model of poly(dG)·poly(dC). Eur. J. Biochem. 1999, 261, 413-420.
64. Ohishi, H.; Terasoma, N.; Nakanishi, I.; van der Marel, G.; van Boom, J.H.; Rich, A.; Wang, A.H.; Hakoshima, T.; Tomita, K. Interaction between left-handed Z-DNA and polyamine-3. The crystal structure of the d(CG)3 and thermospermine complex. FEBS Lett. 1996, 398, 291-296.
65. Ouameur, A.A.; Tajmir-Riahi, H.A. Structural analysis of DNA interactions with biogenic polyamines and cobalt(III)hexamine studied by Fourier transform infrared and capillary electrophoresis. J. Biol. Chem. 2004, 279, 42041-42054.
66. Marky, L.A.; Snyder, J.G.; Breslauer, K.J. Calorimetric and spectroscopic investigation of drug-DNA interactions: II. Dipyrandium binding to poly d(AT). Nucleic Acids Res. 1983, 11, 5701-5715.
67. Antony, T.; Thomas, T.; Shirahata, A.; Thomas, T.J. Selectivity of polyamines on the stability of RNA-DNA hybrids containing phosphodiester and phosphorothioate oligodeoxyribonucleotides. Biochemistry 1999, 38, 10775-10784.
68. Gyi, J.I.; Conn, G.L.; Lane, A.N.; Brown, T. Comparison of the thermodynamic stabilities and solution conformations of DNA·RNA hybrids containing purine-rich and pyrimidine-rich strands with DNA and RNA duplexes. Biochemistry 1996, 35, 12538-12548.
69. Arya, D.P.; Coffee, R.L., Jr.; Willis, B.; Abramovitch, A.I. Aminoglycoside-nucleic acid interactions: Remarkable stabilization of DNA and RNA triple helices by neomycin. J. Am. Chem. Soc. 2001, 123, 5385-5395.
70. Arya, D.P.; Xue, L.; Willis, B. Aminoglycoside (neomycin) preference is for A-form nucleic acids, not just RNA: Results from a competition dialysis study. J. Am. Chem. Soc. 2003, 125, 10148-10149.
71. Hamilton, P.L.; Arya, D.P. Natural product DNA Major groove binders. Nat. Prod. Rep. 2012, 29, 134-143.
72. Xi, H.; Davis, E.; Ranjan, N.; Xue, L.; Hyde-Volpe, D.; Arya, D.P. Thermodynamics of nucleic acid -shape readout" by an aminosugar. Biochemistry 2011, 50, 9088-9113.
73. Xi, H.; Gray, D.; Kumar, S.; Arya, D.P. Molecular recognition of single-stranded RNA: Neomycin binding to poly(A). FEBS Lett. 2009, 583, 2269-2275.
74. Kumar, S.; Xue, L.; Arya, D.P. Neomycin-neomycin dimer: An all-carbohydrate scaffold with high affinity for AT-rich DNA duplexes. J. Am. Chem. Soc. 2011, 133, 7361-7375.
75. Shaw, N.N.; Xi, H.; Arya, D.P. Molecular recognition of a DNA:RNA hybrid: Sub-nanomolar binding by a neomycin-methidium conjugate. Bioorg. Med. Chem. Lett. 2008, 18, 4142-4145.
76. Xue, L.; Ranjan, N.; Arya, D.P. Synthesis and spectroscopic studies of the aminoglycoside (neomycin)-perylene conjugate binding to human telomeric DNA. Biochemistry 2011, 50, 2838-2849.
77. Willis, B.; Arya, D.P. Recognition of B-DNA by neomycin-Hoechst 33258 conjugates. Biochemistry 2006, 45, 10217-10232.
78. Arya, D.P.; Xue, L.; Tennant, P. Combining the best in triplex recognition: Synthesis and nucleic acid binding of a BQQ-neomycin conjugate. J. Am. Chem. Soc. 2003, 125, 8070-8071.
79. Xue, L.; Charles, I.; Arya, D.P. Pyrene-neomycin conjugate: Dual recognition of a DNA triple helix. Chem. Commun. (Camb) 2002, 1, 70-71.
80. Xi, H.; Kumar, S.; Dosen-Micovic, L.; Arya, D.P. Calorimetric and spectroscopic studies of aminoglycoside binding to AT-rich DNA triple helices. Biochimie 2010, 92, 514-529.
81. Willis, B.; Arya, D.P. Triple recognition of B-DNA by a neomycin-Hoechst 33258-pyrene conjugate. Biochemistry 2010, 49, 452-469.
82. Rosenberg, B.; Vancamp, L.; Krigas, T. Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature 1965, 205, 698-699.
83. Pruefer, F.G.; Lizarraga, F.; Maldonado, V.; Melendez-Zajgla, J. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J. Chemother. 2008, 20, 348-354.
84. Vrana, O.; Brabec, V.; Kleinwachter, V. Polarographic studies on the conformation of some platinum complexes: Relations to anti-tumour activity. Anticancer Drug Des. 1986, 1, 95-109.
85. Brabec, V.; Kleinwachter, V.; Butour, J.L.; Johnson, N.P. Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophys. Chem. 1990, 35, 129-141.
86. Heringova, P.; Kasparkova J.; Brabec, V. DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes. J. Biol. Inorg. Chem. 2009, 14, 959-968.
87. Ming, L.J. Structure and function of -metalloantibiotics. Med. Res. Rev. 2003, 23, 697-762.
88. Itzhaki, L.; Weinberger, S.; Livnah, N.; Berman, E. A unique binding cavity for divalent cations in the DNA-metal-chromomycin A3 complex. Biopolymers 1990, 29, 481-489.
89. Gaboriau, F.; Kreder, A.; Clavreul, N.; Moulinoux, J.P.; Delcros, J.G.; Lescoat, G. Polyamine modulation of iron uptake in CHO cells. Biochem. Pharmacol. 2004, 67, 1629-1637.
90. Hou, M.H.; Lu, W.J.; Huang, C.Y.; Fan, R.J.; Yuann, J.M. Effects of polyamines on the DNA-reactive properties of dimeric mithramycin complexed with cobalt(II): Implications for anticancer therapy. Biochemistry 2009, 48, 4691-4698.